DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Amrami-Weizman A, Maayan R, Gil-Ad I. et al.
The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.
Psychopharmacology 2013;
230: 23-27
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.